SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $10,887,000 | +23.9% | 63,856 | +2.0% | 0.10% | -9.0% |
| Q3 2020 | $8,789,000 | -49.7% | 62,584 | -42.6% | 0.11% | -51.5% |
| Q2 2020 | $17,472,000 | +65.5% | 108,970 | +1.0% | 0.23% | +28.7% |
| Q1 2020 | $10,555,000 | -25.9% | 107,904 | -2.2% | 0.18% | +11.9% |
| Q4 2019 | $14,235,000 | +68.7% | 110,317 | -1.6% | 0.16% | +59.0% |
| Q3 2019 | $8,440,000 | -50.5% | 112,056 | -0.2% | 0.10% | -49.7% |
| Q2 2019 | $17,058,000 | +27.8% | 112,258 | +0.3% | 0.20% | +17.8% |
| Q1 2019 | $13,344,000 | -7.9% | 111,952 | -15.7% | 0.17% | -19.1% |
| Q4 2018 | $14,489,000 | -34.7% | 132,767 | -3.4% | 0.21% | -8.7% |
| Q3 2018 | $22,205,000 | +15.2% | 137,485 | -5.7% | 0.23% | +9.6% |
| Q2 2018 | $19,279,000 | +79.3% | 145,854 | +0.5% | 0.21% | +65.9% |
| Q1 2018 | $10,754,000 | +28.7% | 145,145 | -3.3% | 0.13% | +26.0% |
| Q4 2017 | $8,354,000 | – | 150,150 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |